Stockholders approve Series B conversion price cut to $1.50 and 2022 equity plan expansion

MANGOCEUTICALS, INC.

Series B Preferred conversion price reduced to $1.50 (from $2.25); floor price removed; dividend rights eliminated.
2022 Equity Incentive Plan amended: share reserve 10M shares, evergreen up to 2M shares/yr, max 26M shares.
Stockholders approved issuance of Mango & Peaches subsidiary shares to CEO Jacob Cohen under Nasdaq Rule 5635.
All four proposals approved at March 17, 2025 special meeting; Proposal 1 received 98.8% common and 100% Series B votes.
Designation Amendment filed with Texas Secretary of State on March 17, 2025, effective upon stockholder approval.

item 3.02 item 5.03 item 3.03 item 5.02 item 5.07 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.